New Genetic Lab Test Non-Invasive Prenatal Testing Conference 2018
 
Dr. Braulio Peramo Moya
Medical Director
Al Ain Fertility clinic

Dr. Braulio Peramo, an Obstetrician, Gynecologist and IVF physician, is the Medical Director and the General Manager of the Al Ain Fertility Center (AAFC). Dr. Peramo has been internationally practicing in the field of reproductive medicine, specializing in Assisted Reproductive Techniques (ARTs), gynecology and andrology for almost two decades in the USA, UK, mainland Europe and UAE.

Dr. Peramo obtained his Medical and Surgery degree from the University of Madrid in 1991. Following this, he received his obstetrics and gynecology training in Doce de Octubre Hospital Universitario, where his work won the XVIII Prize of the Gynecological Society of Madrid in 1995. Later in 1997, he became a Clinical Fellow of Obstetrics and Gynecology during his visit at the Florida Hospital in Orlando, USA.

In 2004, Dr. Peramo was awarded a Masters in Reproductive Medicine from the Universidad Complutense de Madrid, and in 2007, he attended advanced workshops on IVF and infertility in the New York University, USA. In January 2008, he received the European Diploma of Gynecological Endoscopy from the University of Auvergne in Clermont-Ferrand, France.

 
Dr. Stephen Little Ph.D.
CEO
Premaitha Health PLC
Dr. Stephen is a successful serial biotechnology entrepreneur. He is the former CEO of DxS, an innovator in the field of personalised medicine, developing and manufacturing companion diagnostics. DxS was funded with £3.5M in 2001 and was sold to QIAGEN BV in 2009 for £85M. DxS pioneered the use of molecular diagnostic tests such as KRAS and EGFR mutation analysis to predict the use of novel cancer therapies. In 2009, DxS was acquired by QIAGEN and Dr. Stephen became Vice President of Personalised Healthcare, responsible for developing companion diagnostic partnerships with the pharma industry. Prior to his leading role at DxS, Dr. Stephen worked for 20 years in various senior positions in the diagnostic divisions of Astra Zeneca and ICI. He holds a PhD from Heriot-Watt University in Edinburgh.